Pillstats
Rx only · Capsule, Liquid Filled · Oral

Tafamidis Meglumine

Brands: Vyndaqel · Tafamidis Meglumine

0 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US1 NDCs
0 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN07XX08
RxCUI (US)1545063
US makers1 labelers
Packages1
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

Only one quarter on record so far — the trend line fills in as more quarters load.

12
Rx · 2025 Q4
1.2K
Units dispensed
1
Quarters · since 2025 Q4

Who makes it0 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Pfizer Laboratories Div Pfizer Incunknown1EXITED 2027

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 29, 2025
    RESOLVEDShortage resolved: Tafamidis Meglumine Capsule (Pfizer Inc.)

    Tafamidis Meglumine Capsule — reported in shortage by Pfizer Inc.. Therapeutic category: Cardiovascular.

  • Sep 29, 2025
    SHORTAGEDrug shortage: Tafamidis Meglumine Capsule (Pfizer Inc.)

    Tafamidis Meglumine Capsule — reported in shortage by Pfizer Inc.. Therapeutic category: Cardiovascular.